Patent details

Basic Information

Publication number:

EP1482932

PCT Application Number:

PCT/US/2003/007864

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP037141488

PCT Publication Number:

WO/2003/077914

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

N3 ALKYLATED BENZIMIDAZOLE DERIVATIVES AS MEK INHIBITORS

French Title of Invention:

UTILISATION DE DERIVES DE BENZIMIDAZOLE ALKYLES N3 EN TANT QU'INHIBITEURS DE MEK

German Title of Invention:

N3-ALKYLIERTE BENZIMIDAZOL-DERIVATE ALS MEK-HEMMER

SPC Number:

LUC00100

Dates

Filing date:

13/03/2003

Grant date:

25/11/2009

EP Publication Date:

25/11/2009

PCT Publication Date:

25/09/2003

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

08/12/2004

EP B1 Publication Date:

25/11/2009

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

13/03/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

31/05/2021

 

 

Name:

ASTRAZENECA AB

Address:

VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

Name:

Array BioPharma Inc.

Address:

3200 Walnut Street, Boulder, CO 80301, United States (US)

History of Owners

From:

05/04/2016

To:

31/05/2021

Name:

ASTRAZENECA AB

Address:

VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

From:

13/03/2003

To:

31/05/2021

Name:

Array BioPharma Inc.

Address:

3200 Walnut Street, Boulder, CO 80301, United States (US)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/11/2009

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

MARLOW Allison, L.

Address:

United States (US)

2

Name:

LYSSIKATOS Joseph, P.

Address:

United States (US)

3

Name:

HURLEY Brian, T.

Address:

United States (US)

4

Name:

WALLACE Eli, M.

Address:

United States (US)

Licencee

Name:

PIERRE FABRE MEDICAMENT

From:

27/12/2017

Address:

PLACE ABEL- GANCE 45, 92100, BOULOGNE, France (FR)

To:

27/12/2017

Priority

Priority Number:

364007 P

Priority Date:

13/03/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/4184;

Publication

Bulletin

1

Bulletin Heading:

MED

Bulletin edition number:

2018/03

Publication date:

20/02/2018

Description:

Section K : Modifications and recordals into the register

2

Bulletin Heading:

MED

Bulletin edition number:

2019/11

Publication date:

29/10/2019

Description:

Section K : Modifications and recordals into the register

3

Bulletin Heading:

CO

Bulletin edition number:

2021/07

Publication date:

03/06/2021

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

Deed

Licence

Change Kind/ Decision Type:

New licence registration

Deed Number:

RC20170000465A

Date Registered:

27/12/2017

Licence Effective Date:

27/12/2017

Licence Expiration Date:

13/03/2023

Scope of Licence:

Exclusive

Deed Filer:

NOVAGRAAF TECHNOLOGIES

Journal Edition Number:

Text:

Country Code:

Luxembourg (LU)

Updated Licence Number:

Terminated Licence Number:

Added Licencee(s)

Name:

PIERRE FABRE MEDICAMENT

Address:

PLACE ABEL- GANCE 45, 92100, BOULOGNE, France (FR)

Removed Pledgee

Name:

Address:

Correction of Inscription

Change Kind/ Decision Type:

Based on request sender

Deed Number:

RC20190000314A

Date Registered:

27/08/2019

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

KIRKPATRICK SA / NV

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20210000208A

Date Registered:

31/05/2021

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

OFFICE FREYLINGER S.A.

Journal Edition Number:

Text:

fusion-absorption

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

1

Name:

ASTRAZENECA AB

Address:

VÄSTRA MÄLAREHAMNEN 9, 151 85, SÖDERTÄLJE, Sweden (SE)

2

Name:

Array BioPharma Inc.

Address:

3200 Walnut Street, Boulder, CO 80301, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

17/02/2022

Last Annual Fee Paid Number:

20

Last Annual Fee Paid Amount:

300 Euro

Payer:

MASTER DATA CENTER INC (ex Clarivate Analytics)

Filing date	Document type	Number of pages
02/09/2019	Outgoing Correspondence	1
03/01/2018	Outgoing Correspondence	1
27/12/2017	Request For Change	11
31/05/2021	Outgoing Correspondence	2
31/05/2021	Request For Change	9
27/08/2019	Request For Change	9